Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048

This publication has 22 references indexed in Scilit:

• Time to health-related quality of life score deterioration as a modality of longitudinal analysis for health-related quality of life studies in oncology: do we need RECIST for quality of life to achieve standardization?
  Quality of Life Research, 2013
• Body image in patients with head and neck cancer: A review of the literature
  Oral Oncology, 2013
• Quality-of-life among head and neck cancer survivors at one year after treatment – A systematic review
  European Journal of Cancer, 2012
• Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials? by G. F. Liu, K. Lu, R. Mogg, M. Mallick and D. V. Mehrotra, Statistics in Medicine 2009; 28:2509–2530
  Statistics in Medicine, 2010
• Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials?
  Statistics in Medicine, 2009
• Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum‐based therapies
  Cancer, 2008
• A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients
  European Journal of Cancer, 2000
• Quality of Life in Head and Neck Cancer Patients: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35
  Journal of Clinical Oncology, 1999
• The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
  JNCI: Journal of the National Cancer Institute, 1993
• EuroQol - a new facility for the measurement of health-related quality of life
  Health Policy, 1990